Local interleukin 2 therapy is most effective against cancer when injected intratumourallyJACOBS, John J. L; SPARENDAM, Derek; DEN OTTER, Willem et al.Cancer immunology and immunotherapy. 2005, Vol 54, Num 7, pp 647-654, issn 0340-7004, 8 p.Article

Cell damage, aging and transformation : A multilevel analysis of carcinogenesisRUBIN, H.Anticancer research. 1999, Vol 19, Num 6A, pp 4877-4886, issn 0250-7005Article

Role of p53 and apoptosis in carcinogenesisXIN WEI WANG.Anticancer research. 1999, Vol 19, Num 6A, pp 4759-4771, issn 0250-7005Article

Genetic, epigenetic, dysgenetic and non-genetic mechanisms in tumorigenesis. II. Further delineation of the rate limiting stepSIMONS, J. W. I. M.Anticancer research. 1999, Vol 19, Num 6A, pp 4781-4789, issn 0250-7005Article

The role of molecular discreteness in normal and cancerous growthMICHAELSON, J.Anticancer research. 1999, Vol 19, Num 6A, pp 4853-4867, issn 0250-7005Article

Complementarity and contradiction in cancer research : The role of hierarchies in carcinogenesisROOT-BERNSTEIN, R. S.Anticancer research. 1999, Vol 19, Num 6A, pp 4915-4918, issn 0250-7005Article

Genomic instability : First step to carcinogenesisSCHMUTTE, C; FISHEL, R.Anticancer research. 1999, Vol 19, Num 6A, pp 4665-4696, issn 0250-7005Article

Pernicious cachexia : A different view of cancerZAJICEK, G.Anticancer research. 1999, Vol 19, Num 6A, pp 4907-4912, issn 0250-7005Article

Evaluation : Complementarity and contradictoriness of cancer theories. A genetic perspectiveDEN OTTER, W.Anticancer research. 1999, Vol 19, Num 6A, pp 4913-4914, issn 0250-7005Article

Mechanisms of macrophage cytotoxicity in IL-2 and IL-12 mediated tumour regressionMASZTALERZ, Agnieszka; VAN ROOIJEN, Nice; DEN OTTER, Willem et al.Cancer immunology and immunotherapy. 2003, Vol 52, Num 4, pp 235-242, issn 0340-7004, 8 p.Article

The roles of telomeres and telomerase in cellular immortalization and the development of cancerKLINGELHUTZ, A. J.Anticancer research. 1999, Vol 19, Num 6A, pp 4823-4830, issn 0250-7005Article

Predictive value of CD8highCD57+ lymphocyte subset in interferon therapy of patients with renal cell carcinomaCHARACIEJUS, Dainius; PASUKONIENE, Vita; KAZLAUSKAITE, Nijole et al.Anticancer research. 2002, Vol 22, Num 6B, pp 3679-3683, issn 0250-7005, 5 p.Article

OncogenesTODD, R; WONG, D. T. W.Anticancer research. 1999, Vol 19, Num 6A, pp 4729-4746, issn 0250-7005Article

The role of oval cells and Gap Junctional intercellular communication in hepatocarcinogenesisRUCH, R. J; TROSKO, J. E.Anticancer research. 1999, Vol 19, Num 6A, pp 4831-4838, issn 0250-7005Article

Further development of local IL-2 therapy of cancer: multiple versus single IL-2 treatment of transplanted murine colon carcinomaKUSNIERCZYK, Halina; PAJTASZ-PIASECKA, Elzbieta; KOTEN, Jan-Willem et al.Cancer immunology and immunotherapy. 2004, Vol 53, Num 5, pp 445-452, issn 0340-7004, 8 p.Article

Treatment with IL-2 and IL-12 inhibits tumour cell division in SL2 lymphomaMASZTALERZ, Agnieszka; VAN LUYN, Marja; WERNER, Naomi et al.Anticancer research. 2004, Vol 24, Num 5A, pp 2633-2642, issn 0250-7005, 10 p.Article

Peripheral Blood CD8highCD57+ Lymphocyte Levels May Predict Outcome in Melanoma Patients Treated with Adjuvant Interferon-αCHARACIEJUS, Dainius; PASUKONIENE, Vita; JONUSAUSKAITE, Renata et al.Anticancer research. 2008, Vol 28, Num 2B, pp 1139-1142, issn 0250-7005, 4 p.Article

Therapeutic efficacy of IL-2-loaded hydrogels in a mouse tumor modelDE GROOT, Cornelis J; CADEE, Jenny A; KOTEN, Jan-Willem et al.International journal of cancer. 2002, Vol 98, Num 1, pp 134-140, issn 0020-7136Article

The mechanism of regression of solid SL2 lymphosarcoma after local IL-2 therapyBASELMANS, Anton H. C; KOTEN, Jan-Willem; BATTERMANN, Jan J et al.Cancer immunology and immunotherapy. 2002, Vol 51, Num 9, pp 492-498, issn 0340-7004, 7 p.Article

Epilogue : What we don't know about cancerWITTE, M. H; WITTE, C. L.Anticancer research. 1999, Vol 19, Num 6A, pp 4919-4933, issn 0250-7005Article

Chromosomal abnormalities : Detection and implications for cancer developmentDOS SANTOS, N. R; VAN KESSEL, A. G.Anticancer research. 1999, Vol 19, Num 6A, pp 4697-4714, issn 0250-7005Article

Tumor suppressor genes (TSG)BIN TEAN TEH; LARSSON, C; NORDENSKJÖLD, M et al.Anticancer research. 1999, Vol 19, Num 6A, pp 4715-4728, issn 0250-7005Article

A simple stochastic model of development and carcinogenesisROOT-BERNSTEIN, R. S; BERNSTEIN, M. I.Anticancer research. 1999, Vol 19, Num 6A, pp 4869-4876, issn 0250-7005Article

Local therapy of cancer with free IL-2DEN OTTER, Willem; JACOBS, John J. L; BATTERMANN, Jan J et al.Cancer immunology and immunotherapy. 2008, Vol 57, Num 7, pp 931-950, issn 0340-7004, 20 p.Article

Oxidation of recombinant human interleukin-2 by potassium peroxodisulfateCADEE, Jenny A; VAN STEENBERGEN, Mies J; VERSLUIS, Cees et al.Pharmaceutical research. 2001, Vol 18, Num 10, pp 1461-1467, issn 0724-8741Article